Tenax Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Author's Avatar
Sep 09, 2021

Tenax Therapeutics, Inc. (Nasdaq: TENX),a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021.